Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse
- PMID: 15204212
- DOI: 10.1080/08039480410006296
Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse
Abstract
The main objective of this study was to compare symptom load and lifetime treatment experiences between psychotic patients with substance abuse problems and psychotic patients without substance abuse problems. This is a cross-sectional study of 48 patients (26 inpatients and 22 outpatients) in a clinic for early intervention in psychosis. Patients' were grouped into two categories based on whether they had a substance abuse problem or not. Twenty-one (43.8%) had a substance abuse problem and 27 (56.2%) had not. We used the Positive and Negative Symptom Scale (PANSS) scale to measure symptoms and several scales to measure substance abuse. Parametric tests (independent t-tests) were used to compare continuous variables, and chi-square tests were used to compare frequencies. Positive symptoms, negative symptoms, general psychopathology symptoms and the total score of psychotic symptoms did not differ significantly between the groups with psychosis alone and psychosis with substance abuse. The delusion subscore was significantly higher in the group with psychosis alone (t = -2.3, df = 41, P < 0.05), and the anxiety subscore was significantly higher in the group with psychosis with substance abuse (t = -2.3, df = 41, P < 0.05). There were no significant differences in the subscores for negative symptoms. The absence of differences in psychotic symptoms between the two groups with psychosis does not imply a strong relationship between psychotic symptoms and substance abuse. These results do not support the self-medication hypothesis. The higher rates of institutionalization among substance abusers may be explained by mechanisms other than exacerbations of psychotic symptoms, as there are few differences in symptoms among abusers and non-abusers.
Similar articles
-
The long-term level of functioning in patients admitted for psychotic disorders with and without substance abuse.Nord J Psychiatry. 2006;60(2):121-5. doi: 10.1080/08039480600583811. Nord J Psychiatry. 2006. PMID: 16635930
-
Using brief self-reports and clinician scales to screen for substance use disorders in psychotic patients.Nord J Psychiatry. 2010 Apr;64(2):130-5. doi: 10.3109/08039480903274423. Nord J Psychiatry. 2010. PMID: 19883188
-
Substance use disorders among psychotic patients admitted to inpatient psychiatric care.Nord J Psychiatry. 2009;63(1):72-7. doi: 10.1080/08039480802450439. Nord J Psychiatry. 2009. PMID: 19034727
-
Reasons for increased substance use in psychosis.Clin Psychol Rev. 2007 May;27(4):494-510. doi: 10.1016/j.cpr.2006.09.004. Epub 2007 Jan 19. Clin Psychol Rev. 2007. PMID: 17240501 Review.
-
Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599. Harv Rev Psychiatry. 2009. PMID: 19205964 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous